MarginsXMarginsX
Home › Markets › Health Care › CTSO

Cytosorbents Corporation (CTSO)

CTSO trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$4.85
-0.41% on the day
Market cap
$15.3M
Nano cap
Revenue · 2025
$37.1M
+4.1% on 2024
Net income · 2025
-$8.2M
-22.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1175151/000110465926036451/0001104659-26-036451-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCTSO on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001175151
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$37.1M
Net income-$8.2M
Operating income-$14.7M
Net margin-22.1%
Operating margin-39.8%
Revenue growth+4.1%
Cash$6.2M
Total assets$44.2M
P/E (computed)Net income was not positive
P/S (computed)0.4×

Warning signs

Cash runway
5.8 months
$4.4M cash at June 30, 2026
Share count, 1 year
+0.1%
2025-08-01 to 2026-07-31 · +41.7% over 3 years
Going-concern doubt
Yes
10-Q filed August 6, 2026
Insider net buying, 12 months
$269K
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These cash and restricted cash balances considered with the Company's historical and expected future cash used in operations, notwithstanding the Company's Strategic Workforce and Cost Reduction Plan (see Note 11, Restructuring ) and the impact of the Amended Loan and Security Agreement (see Note 6, Long-Term Debt ) raises substantial doubt about the Company's ability to continue as a going concern within twelve mont"
10-Q 2026-08-06
Cash and burn$4.4M cash; operating cash flow -$2.3M a quarter.Report 2026-06-30
Shares outstanding3,142,137 (2026-07-31); 62,761,805 a year earlier; 44,362,386 three years earlier.Cover page 2026-07-31
Reverse splits, 3 years1; latest 1-for-20 on 2026-09-08Source 2026-09-08
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-07-06
AuditorWithumSmith+Brown, PC, East Brunswick, New Jersey, United StatesPCAOB Form AP 2026-04-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $269K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
$9.6M-$4.4M-$583K$4.4M$17.2M$37.2M10-Q 2026-08-06
Q1 2026
2026-03-31
$8.9M-$5.1M-$1.2M$4.8M$17.0M$37.2M10-Q 2026-05-13
Q4 2025
2025-12-31
$9.2M-$5.5M-$4.8M$6.2M$16.7M$37.1M10-K 2026-03-30
Q3 2025
2025-09-30
$9.5M-$3.2M-$2.6M$7.5M$14.6M$37.0M10-Q 2025-11-13
Q2 2025
2025-06-30
$9.6M$1.9M-$1.5M$10.2M$14.4M$36.1M10-Q 2026-08-06
Q1 2025
2025-03-31
$8.7M-$1.5M-$3.5M$11.6M$14.2M$35.3M10-Q 2026-05-13
Q4 2024
2024-12-31
$9.2M-$7.6M-$2.3M$3.3M$14.0M$35.6M10-K 2026-03-30
Q3 2024
2024-09-30
$8.6M-$2.8M-$2.5M$5.7M$13.8M$35.1M10-Q 2025-11-13

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52024-12-09
Latest annual report10-K/A2026-04-15
Latest quarterly / interim10-Q2026-08-06
Latest current report8-K2026-11-12
Latest proxyDEFA14A2026-06-25

Source: SEC EDGAR submissions feed, 978 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.5%
1 month+40.8%
3 months-32.7%
Year to date-61.9%
1 year-63.4%
From 52-week high-70.9%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SNWVSANUWAVE Health Inc.$1.81-0.55%$15.6M
PAVMPAVmed Inc.$1.75+7.36%$14.0M
RVPRetractable Technologies Inc.$0.5600+0.02%$16.8M
CVRXCVRx Inc.$0.6130+0.92%$17.5M
GUTSFractyl Health Inc.$0.9918+9.76%$13.2M
PMIPicard Medical Inc.$7.24+0.14%$17.8M
DRIODarioHealth Corp.$1.15-8.73%$13.0M
MODDModular Medical Inc.$1.91-3.05%$18.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier